Acta Scientific Gastrointestinal Disorders (ASGIS)(ISSN: 2582-1091)

Case Report Volume 7 Issue 1

Mucinous Ovarian Adenocarcinoma Cloaked as an Intestinal Tumor-Case Report

Mazzini LR1*, Ramalho DW1, Ibarrola EMS2, Del Ben MG3, Gobbo LC3 and Teixeira GZ4

1Medical Student at the Pontifícia Universidade Católica de Campinas, School of Life Sciences, Brazil
2Medical Student at the University Nove de Julho, Brazil
3Medical Doctor at the Residency program in General Surgery at Celso Pierro Hospital and Maternity, PUC-Campinas Hospital, Brazil
4Assistant Physician of the Surgery, Urgency and Trauma Service (SCUT) of the Celso Pierro Hospital and Maternity, PUC-Campinas Hospital, Brazil

*Corresponding Author: Mazzini LR, Medical Student at the Pontifícia Universidade Católica de Campinas, School of Life Sciences, Brazil.

Received: October 30, 2023; Published: December 02, 2023


Ovarian mucinous neoplasia are extremely heterogeneous tumors in morphology and clinical presentation, being a setback for the appropriate diagnosis. Cross-reactions and immunohistochemical ambiguity are adversities that limit accuracy, leading to the need for greater resourcefulness in the management of these patients. Because it is a neoplasm with a high probability of becoming invasive, surgical excision is usually the most assertive alternative.

Keywords: Adenocarcinoma; Mucinous; Intestine; Ovary


  1. BLOSS, Jeffrey D., et al. “Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary”. Gynecologic Oncology3 (1993): 347-351.
  2. MORITANI Suzuko., et al. “Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP-15 useful in differential diagnosis?” Human Pathology5 (2008): 666-671.
  3. DE FREITAS OLIVEIRA Laura., et al. “Adenocarcinoma mucinoso com alto grau de malignidade-relato de caso”. Brazilian Journal of Development8 (2021): 76790-76797.
  4. SCHMELER Kathleen M., et al. “Prevalence of lymph node metastasis in primary mucinous carcinoma of the ovary”. Obstetrics and Gynecology201 (2010): 269.
  5. HART William R. “Mucinous tumors of the ovary: a review”. International Journal of Gynecological Pathology1 (2005): 4-25.
  6. SEIDMAN Jeffrey D., et al. “Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis”. The American Journal of Surgical Pathology7 (2003): 985-993.
  7. Tabrizi Ali Dastranj MD., et al. “Primary Ovarian Mucinous Carcinoma of Intestinal Type: Significance of Pattern of Invasion and Immunohistochemical Expression Profile in a Series of 31 Cases”. International Journal of Gynecological Pathology2 (2010): 99-107.
  8. SHIN Jung Ha., et al. “CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma”. Japanese Journal of Clinical Oncology3 (2010): 208-213.
  9. GROISMAN Gabriel M., et al. “The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries”. International Journal of Gynecological Pathology1 (2004): 52-57.
  10. FORTES NETO., et al. “Difficulties in diagnosing colorectal cancer with ovarian metastasis: a literature review”. Research, Society and Development 16 (2021): e376101623904.
  11. RICCI Francesca., et al. “Recent insights into mucinous ovarian carcinoma”. International Journal of Molecular Sciences6 (2018): 1569.
  12. GOUY Sebastien., et al. “Characteristics and prognosis of stage I ovarian mucinous tumors according to expansile or infiltrative type”. International Journal of Gynecologic Cancer3 (2018).
  13. BELLIZZI Andrew M. “An algorithmic immunohistochemical approach to define tumor type and assign site of origin”. Advances in Anatomic Pathology3 (2020): 114.
  14. KUBEČEK Ondřej., et al. “The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review”. Clinical and Experimental Metastasis5 (2017): 295-307.
  15. GORRINGE Kylie L., et al. “Therapeutic options for mucinous ovarian carcinoma”. Gynecologic Oncology3 (2020): 552-560.
  16. KÖBEL Martin and KANG Eun Young. “The evolution of ovarian carcinoma subclassification”.Cancers2 (2022): 416.
  17. RAMALINGAM Preetha. “Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer”. Oncology (Williston Park, NY)2 (2016): 166-176.
  18. SCHIAVONE Maria B., et al. “Natural history and outcome of mucinous carcinoma of the ovary”. American Journal of Obstetrics and Gynecology5 (2011): 480. e1-480. e8.


Citation: Mazzini LR., et al. “Mucinous Ovarian Adenocarcinoma Cloaked as an Intestinal Tumor-Case Report"..Acta Scientific Gastrointestinal Disorders 7.1 (2024): 06-09.


Copyright: © 2023 Mazzini LR., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate35%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US